January 2017 – Molecular and Cellular Immunotherapy Initiative
TheThe Board of Visitors awarded $1.5 Million to accelerate progress toward breakthroughs in both cell based and molecular immunotherapy. Specifically, these funds will support:
1. Expansion of laboratory and manufacturing facilities and personnel to produce cell therapy products
2. Clinical trials for development of cell therapy related protocols for treatment of patients with brain tumors, primary immune deficiencies, and food allergies
3. Pilot projects for a cancer vaccine and for therapeutic antibody development
4. A bioinformatics core and development of humanized animal disease models
TheScientific discoveries in these areas will speed the delivery of new treatments and cures developed specifically for pediatric patients with cancer and other life-threatening diseases to improve the survival and quality of life for these children.
January 2017 – Epilepsy and Functional Neurosurgical Imaging Center
The Board of Visitors awarded $200,000 to William Gaillard, MD, Chief, Epilepsy and Neurophysiology. Our funding will help expand treatment opportunities for children with epilepsy.
May 2015 – Seacrest Studios
The Board of Visitors awarded $400,000 to the launch of the Seacrest Studio at Children’s National. The Ryan Seacrest Studio at Children’s National is the 9th state-of-the-art broadcast studio and media center to be opened at a major children’s hospital in the country. The Seacrest Studio will enable children while in the hospital to explore the creative realms of radio, television, new media, and educational programming. By raising a child’s spirit and tapping into their imagination this resource will encourage coping and promote healing during treatment.
May 2014 – Cerebral Palsy Prevention Program
The Board of Visitors awarded $700,000 to launch The Board of Visitors Cerebral Palsy Prevention Program. The program’s launch will allow for the accelerated testing of new treatments and rapidly apply them to babies with a high risk of developing life-long neurological disabilities. The program will also forge new collaborations between clinicians and researchers, and raise awareness of Cerebral Palsy among policy-makers and future philanthropic supporters. In part due to the BOV’s funding and partnership, Children’s National expects that new solutions will be found to protect the brain development of the most fragile newborns as well as mitigate the effects in children living with Cerebral Palsy.
February 2013 – Genetic Medicine / Program for Personalized Pediatric Cancer Research
1. The Board of Visitors Awarded $495,293 to purchase a state-of-the-art Q Exactive Mass Spectrometer for the Proteomics Core Facility of the Research Center for Genetic Medicine. Mass spectrometers identify and quantify proteins (the building blocks of all life) in biological samples. The Q Exactive monitors how proteins change in a disease state or in response to treatment, providing greater insight to disease and therapeutic biology. It provides a ten-fold increase in capabilities and is the most advanced equipment of its kind to come to the DC metropolitan area. This technology is applicable to any disease or therapy and will immediately benefit more than 30 laboratories at Children’s National and throughout the DC area.
2. The Board of Visitors Awarded $600,000 to fund The Board of Visitors Program for Personalized Pediatric Cancer Research in the Center for Cancer and Immunology Research at Children’s National. This gift helps Children’s National become one of the few hospitals in the country to launch comprehensive research to personalize cancer treatment for children.
October 2012 – Palliative Care Services
The Board of Visitors awarded $150,000 to expand Palliative Care Services at Children’s National—known as the Pediatric Advanced NeeDs Assessment (PANDA) care team. Together with a matching award by the Children’s Health Board, Children’s National can now provide a more comprehensive interdisciplinary palliative care team. The PANDA team addresses the psychosocial, emotional and spiritual needs of patients and families, from the time of diagnosis of a potentially life-limiting illness through survivorship, or end of life, if that is the ultimate outcome. Because there are no other dedicated pediatric hospice or palliative care services in the DC metropolitan area, this funding fulfills a crucial need in the community.
May 2011 – Simulation Learning Program
The Board of Visitors announced a Major Gift to Children’s National of $1 Million to develop The Board of Visitors Simulation Learning Program—one of America’s most advanced pediatric simulation programs. The Program provides a safe, non-threatening environment for clinicians to practice procedures and mimic emergency situations tailored specifically for their areas of practice and helps improve the quality and safety of patient care. This gift represents an ongoing commitment by The Board of Visitors to support simulation training at Children’s National. In 2006, The Board awarded a Major Gift in the amount of $250,000 to create and equip The Board of Visitors Simulation Learning Center. The Center, comprised of two patient care areas, contains state-of-the-art technology and provides a more realistic learning experience for caregivers.